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A B S T R A C T
Background: Before introducing proteins from new or alternative dietary sources into the market, a compressive
risk assessment including food allergic sensitization should be carried out in order to ensure their safety. We
have recently proposed the adverse outcome pathway (AOP) concept to structure the current mechanistic un-
derstanding of the molecular and cellular pathways evidenced to drive IgE-mediated food allergies. This AOP
framework offers the biological context to collect and structure existing in vitro methods and to identify missing
assays to evaluate sensitizing potential of food proteins.
Scope and approach: In this review, we provide a state-of-the-art overview of available in vitro approaches for
assessing the sensitizing potential of food proteins, including their strengths and limitations. These approaches
are structured by their potential to evaluate the molecular initiating and key events driving food sensitization.
Key findings and conclusions: The application of the AOP framework offers the opportunity to anchor existing
testing methods to specific building blocks of the AOP for food sensitization. In general, in vitro methods eval-
uating mechanisms involved in the innate immune response are easier to address than assays addressing the
adaptive immune response due to the low precursor frequency of allergen-specific T and B cells. Novel ex vivo
culture strategies may have the potential to become useful tools for investigating the sensitizing potential of food
proteins. When applied in the context of an integrated testing strategy, the described approaches may reduce, if
not replace, current animal testing approaches.
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1. Introduction
Food allergy is one of the most common health disorders in the
western world. The occurrence of food allergy drastically increased in
the last decades with a current prevalence that reaches up to 10% of the
population (Sicherer & Sampson, 2018). Food allergies are adverse re-
actions to an otherwise harmless food or food component that involves
an abnormal response of the body's immune system to specific protein
(s) in food. The clinical picture of food allergy is pleiomorphic and can
range from gastrointestinal symptoms to severe anaphylaxis
(Eigenmann et al., 2008). Most (approximately 90%) of food allergic
reactions are caused by milk, egg, peanuts, tree nuts, fish, soya, wheat
and shell fish (Boyce, Assa, Burks, Jones, & Hugh, 2010). Allergic dis-
ease develops in a two-step process comprising sensitization to the al-
lergenic food and subsequent elicitation of the allergic reaction re-
sulting in symptoms on re-exposure to the allergen.
The contribution of food proteins to healthy aging is increasingly
documented and the role of these proteins in a healthy diet recognized.
However, a growing global population places an increased pressure on
the world's resources to provide not only more but also different types
of food. The development and introduction of new dietary protein
sources has the potential to improve food supply sustainability. This can
be achieved via different ways, e.g. through development of new nu-
tritional/protein sources, improvement of crops, by providing solutions
to technical challenges during manufacturing, as well as by valorizing
unused side products (Remington et al., 2018; Selb et al., 2017). These
foods must not pose a risk to public health, thus a comprehensive risk
assessment should be conducted in order to ensure their safety. Risk
assessment should cover different domains including kinetics, tox-
icology, nutritional effects and allergenicity (de Boer & Bast, 2018).
Studying the allergenicity of these foods is quite complex. Firstly,
relevant allergenic testing material needs to be obtained. To this end,
several factors (e.g. pH, buffer, fatty substances in matrix etc), should
be taken into consideration to obtain an extract that provides a good
picture of the novel food, which have to be optimized case-by-case
(Mazzucchelli et al., 2018). In addition, the purification of proteins
might also be also technically challenging and may result in chemical
modifications, which needs to be assessed prior to testing for aller-
genicity (Mazzucchelli et al., 2018). Next to the difficulties to obtain
relevant allergenic testing material, it is evident that properties of food
matrix components are also relevant and important in the sensitization
process. The allergen is never in initial contact with the immune system
in a purified state; the matrix surrounds, interacts with, and can affect
the physiochemical features of the allergens. Currently, the primary
influences of the matrix are thought to be antigen bioavailability and
release, digestibility and interactions with the immune system
(McClain, Bowman, Fernández-Rivas, Ladics, & Van Ree, 2014). How-
ever there are no straightforward approaches to address the many
variables represented by the matrix components in food (reviewed by
McClain et al., 2014), so additional knowledge is required which will
help to develop tools to incorporate their influence on sensitization into
model systems (van Bilsen et al., 2017).
This manuscript focusses on the current available in vitro tools to
study cellular and molecular mechanisms driving the non-symptomatic
sensitization phase of food allergy resulting in the generation of food
protein-specific IgE.
There are a considerable number of in vivo and in vitro data available
describing molecular and cellular events potentially involved in food
sensitization. Recently, these events have been organized in a sequence
of related processes that is plausible to result in sensitization and useful
to challenge current hypothesis by applying the concept of adverse
outcome pathway (AOP) (van Bilsen et al., 2017). The proposed AOP
framework provides a simplification of a complex biological process by
collecting, organizing and evaluating data that describe the events of an
adverse outcome at a biological level of organization with relevance for
risk assessment. The application of the AOP concept allows to identify
the major molecular initiating events (MIE) and key events (KE) un-
derlying food sensitization (Fig. 1). The AOP for food sensitization
starts with a MIE involving the allergen uptake over the mucosal barrier
of the gut intestine. The food protein passage may induce the activation
of intestinal epithelial cells (IECs), representing KE1, followed by the
local activation of dendritic cells (DCs) and their migration to the me-
senteric lymph nodes (KE2 and KE3). There, DCs present processed
allergen to naive T cells priming them toward a T helper type 2 (Th2)
response (KE4). Thus these events may cause the activation of B cells
(KE5) and the production of specific IgE by plasma cells.
The events included in this AOP are still highly complex at mole-
cular/cellular level, but the challenge is to integrate MIE and KE to
better understand the mechanistic pathways of food sensitization in-
duction. The AOP for food allergy offers the opportunity to anchor
existing methods for the testing and assessment of sensitizing potential
of food proteins. Moreover, it gives insight into which specific assays
are suitable to evaluate the influence of novel food proteins and in-
gredients in the sensitization process.
Fig. 1. A tentative adverse outcome pathway describing the mechanistic events driving food sensitization induction. Depicted are those events and relationships with
substantial evidence for a role in food sensitization induction in human. DC: dendritic cell; *Outside the scope of this manuscript. Adapted from van Bilsen et al.,
2017.
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It is still a matter of debate whether human, like mice, can be
sensitized via other routes than the oral route such as via the skin or
respiratory route. Epidemiological studies in human populations seem
to confirm the skin as a relevant route for food sensitization induction
and allergy in humans, however is mechanistically not sufficiently
understood yet (van Bilsen et al., 2017). Evidence for the respiratory
route is even more ambiguous (van Bilsen et al., 2017). Therefore, in
vitro testing strategies focusing on the dermal or respiratory route are
not explored in this review.
In this review, we aim to provide the state-of-the-art of existing in
vitro approaches for assessing sensitizing potential of food proteins
based on the identified MIE and KE proposed in the AOP for food
sensitization, as described by van Bilsen et al. (van Bilsen et al., 2017).
For this propose, we provide cell assays previously used for the study of
food allergens focusing on major read-outs as well as strengths and
limitations of these assays.
2. Antigen uptake over intestinal mucosal barrier and epithelium
activation
2.1. In vitro models to assess tight junction disruption (MIE1)
During the gastrointestinal digestion, intact proteins and peptide
fragments reach the intestinal lumen where they interact with the IECs
resulting in antigen uptake over the gut barrier. Digestion products may
be transferred across the intestinal epithelium by paracellular transport
driven by disruption of tight junctions, adherent junctions and des-
mosomes, representing MIE1. Tight junctions are multiprotein com-
plexes composed by transmembrane proteins (occludin, claudin, junc-
tional adhesion molecule A and tricellulin) that provide the integrity of
the actomyosin ring, which controls inter-epithelial permeability.
Typically, epithelial in vitro models employed to study the transport
and absorption of food proteins or peptides along the intestinal epi-
thelium are based on cell lines (including Caco-2, HT-29, T84, and
IPEC-J2) grown in a transwell system (Cubells-Baeza et al., 2015). In
this regard, Grozdanovic and co-workers demonstrated that the ex-
posure of T84 cells to actinidin, a kiwifruit cysteine protease, resulted in
the impairment of the epithelial barrier, due to the degradation of oc-
cludin promoted by the proteolytic action of actinidin (Grozdanovic
et al., 2016). As a consequence, an increase of the intestinal perme-
ability was recorded which could contribute to the process of sensiti-
zation in kiwifruit allergy. By employing the Caco-2 cell model, Price
et al. showed that peanut allergens Ara h 1 and Ara h 2 were able to
alter the intestinal barrier permeability, modifying the co-localization
of the transmembrane tight junction proteins occludin, JAM-A and
claudin-1, with the intracellular adhesion protein ZO-1 (Price, Ackland,
Burks, Knight, & Suphioglu, 2014). In another study, β-conglycinin
from soy (Gly m 5) induced a downregulation of tight junction proteins
by using a model of IPEC-J2 porcine cells (Zhao et al., 2015).
On the other hand, the breach of epithelial barrier may be a con-
sequence of Th2 switching and may possibly reflect the abnormal re-
sponses and vicious cycle triggered by mast cell activation. It has been
observed that mast cells releasing chymases and histamine have an
impact on the physiology of the intestinal mucosa, promoting the de-
gradation of the tight junction occludins (Bischoff & Kramer, 2007).
Moreover, mast cells are involved in the release of Th2-realted cyto-
kines, such as IL-4 and IL-13, that influence the modulation of IEC
permeability in different human IEC cultures, decreasing the trans-
epithelial electrical resistance (TEER) and selectively increasing the
apical-to-basal movement of proteins (Ceponis, Botelho, Richards, &
McKay, 2000). In order to address the integrity of the intestinal
monolayer, the study of the TEER is an important issue that provides
information about the inter-epithelial transport, generally associated
with an alteration of the tight junctions and thus relates to paracellular
transport. It has been reported that exposure of crude apple homo-
genate produces an increase of the paracellular resistance in Caco-
2 cells, with an augmentation of the expression of several tight junction
related genes, including claudin 4 (Vreeburg, Bastiaan-Net, & Mes,
2011). Zhao et al. have recently shown that peptides produced during
simulated in vitro digestion of soybean β-conglycinin, determine an
increase of alkaline phosphatase activity with a decrease of mitochon-
drial respiration (MTT assay), TEER values and downregulation of
claudin-3, claudin-4, occludin, and ZO-1 expression (Zhao, Liu, Zhang,
Pan, & Qin, 2017).
However, not all food allergens affect TEER resistance. Moreno et al.
reported that the transcellular transport of purified 2s albumins Ber e 1
(brazil nut) and Ses i 1 (sesame seed) across Caco-2 monolayer did not
affect the permeability as assessed by the absence of any change of
allergen absorption rate and TEER values (Moreno, Rubio, Olano, &
Clemente, 2006). In other work, authors found that hydrolyzed oval-
bumin did not affect MTT values or cell permeability indicating a
protective effect exerted by the food matrix on the cell barrier
(Grootaert et al., 2017). In addition, TEER values were restored to their
original levels, demonstrating the absence of any permanent damage on
the monolayer caused by egg digests tested (Grootaert et al., 2017). In
line with this, previous studies also reported that purified proteins from
wheat (ω5-gliadin and LTP 1) (Bodinier et al., 2007), peach (Pru p 3
and LTP 1) (Tordesillas et al., 2013), and peanut (Ara h 1 and Ara h 2)
(Price, Ackland, & Suphioglu, 2017) were able to cross Caco-2 mono-
layers without compromising cell monolayer integrity.
2.2. In vitro models to assess receptor-mediated and unspecific endocytosis
(MIE2 and MIE3)
Apart from paracellular transport, food proteins may also cross the
intestinal epithelium via transcellular transport pathways, either re-
ceptor-mediated (e.g. CD23, the low affinity FcεRII-IgE receptor)
(MIE2) or via unspecific endocytosis (MIE3).
CD23 is expressed by Caco-2, T84 and HT29 cells and their ex-
pression can be stimulated by IL-4 (Tu et al., 2005). Using Caco-2 cells,
it has been demonstrated that IgE-antigen (nitrophenyl(NP)-BSA)
complexes trigger the upregulation of IL-8 and CCL20. The supernatant
of such triggered Caco-2 cells induced DC migration in a CCL20-de-
pendent manner (Li et al., 2007). In HT29 cells, it has been shown that
CD23 expression and transcellular transport of IgE-NP-ovalbumin
complexes could be stimulated by factors present in supernatant of
activated mast cell (HMC1) and monocyte (THP1) lines (Tu, Oluwole,
Struiksma, Perdue, & Yang, 2009). The role of SIgA in transcytosis has
been studied even less than that of CD23, and mainly focus on gliadin
peptides. Caco-2 and HT29 cells express CD71 and transglutaminase 2
(TG2), both shown to co-precipitate with SIgA and important for en-
dosomal transport routing (Lebreton et al., 2012). These reports on
receptor-mediated endocytosis are from a few isolated studies, but they
show that the role of CD23-mediated and of CD71/TG2 transcytosis
could be examined using in vitro models, although more food proteins
using these assays should be tested.
Unspecific transport of food proteins may occur via epithelial,
goblet or M cells and may result not only in protein degradation within
these cells and cellular activation, but also it can lead to process of
proteins into peptides that can be expressed in the context of MHC-II.
The route of uptake seems to have an important implication for the final
outcome. Although insufficiently studied, it has been proposed that
larger cross-linked proteins could be more sensitizing because they are
preferentially taken up by M cells and directly interact with immune
cells in Peyer's patches. Roth-Walter and co-workers described that the
intestinal transport of soluble β-lactoglobulin occurs through en-
terocytes, while the uptake of its aggregates is redirected to Peyer's
patches (Roth-Walter et al., 2008). On the other hand, smaller intact
proteins are transferred via goblet-associated passage (also called GAP)
and that may be linked to processing by CD103 + DCs, facilitating
tolerance rather than to other DCs that are linked to sensitization
(McDole et al., 2012). M cell transfer and GAP are not often studied
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using in vitromethods, but cell lines as well as organoids can be adapted
to study the particular involvement of these transportation routes. For
instance, cell lines and intestinal stem cell-derived organoids can be
stimulated to form M cells by RANKL-RANK pathway activation
(Kimura, 2018) and GAP could be studied in specialized cell lines
(HT29-H cells) or in organoids (constitutive presence of goblet cells).
Endocytosis is a complex process that includes caveolea-mediated
uptake mechanisms, clathrin-dependent and -independent uptake me-
chanisms, macro-pinocytosis and phagocytosis. These processes may
operate alongside each other and can be studied by using specific in-
hibitors (Dutta & Donaldson, 2012). Important to mention here is that
many of these inhibitors (e.g. filipin, cytochalasinD and mono-
dansylcadaverine) also affect viability as well as TEER values (Price
et al., 2017). Little information with regard to the importance of var-
ious mechanisms of endocytosis is yet available for food allergens. But
studies with individual proteins show that different mechanisms of
endocytosis may be involved for different proteins; for instance, Ara h 1
may be endocytosed via a combination of macro-pinocytosis and cla-
thrin-dependent processes, whereas Ara h 2 may be endocytosed via a
combination of macro-pinocytosis and caveolea-mediated uptake me-
chanisms (Price et al., 2017). Although authors speculate that the lo-
calization of Ara h 2 resulting from the specific way of endocytosis is
linked to higher allergenicity of Ara h 2, other potential explanations
such as their different molecular weight or physico-chemical properties
should be also considered.
Altogether, in vitro models such as Caco-2 cells cultured onto
transwell systems seem suitable to study the importance of MIE2 and
MIE3 in sensitization to food proteins. However, no data is currently
available for ranges of allergens and clearly this information is needed
to link endocytosis per se as well as the type of translocation to the
sensitizing potential of a food protein.
2.3. In vitro models to assess epithelium activation (KE1)
Beyond being transported across the gut epithelial barrier, food
proteins and their digestion products are able to interact with IECs in
the intestinal lumen thereby triggering immune responses. It is widely
accepted that food sensitization involves factors from gut epithelium,
which are released after the activation of IECs (KE1). The presence of
food allergens in the gut is mainly detected by pattern recognition re-
ceptors (PRRs), such as toll like receptors (TLRs), glycan binding re-
ceptors (galectins) or protease-activated receptors (PARs). This leads to
the activation of inflammatory mechanism resulting in the activation of
the NF-κB route and initiate the repair process for the damaged barrier
with the production and secretion of chemokines, cytokines, reactive
oxygen species (ROS), and lipid metabolites.
In vitro studies have closely linked the production of ROS to the
activation of epithelial cells in the case of aeroallergens. The presence
of IL-13 in the environment and the activation of PAR-2 receptor have
been implicated in the upregulation of ROS production by epithelial
cells (Dickinson et al., 2016; Nadeem et al., 2015). However, the effect
of food allergens on IECs have not been so furtherly studied and we can
only report the case of peanut allergens, in which an increase in the
nitric oxide synthase gene expression has been observed (Starkl et al.,
2011).
In response to their activation, IECs are also able to release epi-
thelial-specific cytokines (e.g. IL-1, IL-18, IL-25, IL-33, and the thymic
stromal lymphopoietin –TSLP-) that are crucial for the initiation of food
protein sensitization. This cytokine environment induces the activation
of DCs, type 2 innate lymphoid cells (ILC2), basophils, eosinophils, and
mast cells, skewing the intestinal immune system towards a Th2 re-
sponse. IL-33, IL-25, and TSLP are constitutively expressed by epithelial
cells being IL-33 a crucial regulator of mast cells. Besides that, IL-33 is
able to enhance granulocyte, macrophage, and ILC2 responses (Saluja,
Khan, Church, & Maurer, 2015). IL-25 elicits multipotent progenitor
type 2 cells, a population of innate cells promoting type 2 cell immunity
even in absence of ILC2 (Saenz et al., 2013). Regarding TSLP, its ex-
pression is increased in a NF-κB dependent-manner, being able to ac-
tivate mast cells and influencing antibody production (Miron & Cristea,
2012). On the other hand, the production of IEC-derived TGF-β pro-
motes DCs involved in tolerogenic signals, which is an important
milestone for the control of allergic sensitization (Wang & Sampson,
2009). Tordesillas et al. examined the effect of the major peach allergen
Pru p 3, in comparison with that of the hypoallergenic peach LTP 1
using Caco-2 cells grown in a transwell system. Authors showed that in
the presence of Pru p 3 an increased expression of Th2-driving cyto-
kines (IL-25, IL-33, and TSLP) was observed. However, with the hy-
poallergenic protein LTP 1, the induction these cytokines was sig-
nificantly lower (Tordesillas et al., 2013). In other study, the effect of
the peanut allergen Ara h 2 on IECs showed upregulation of the in-
flammatory cytokines IL-1β and IL-8 (Starkl et al., 2011).
Concluding, the activation of epithelial cells is a heterogeneous
process in which the cytokine environment is crucial, for this reason the
effects of more food allergens on IECS should be described using other
cell types than Caco-2 cells. Despite the fact that the majority of studies
are focused on the analysis of the cytokines expression, other pathways
should be explored, such as mucus secretion or Ca2+-signalling
pathway alterations.
2.4. In vitro models to assess antigen uptake combined with epithelium
activation (MIE and KE1)
Approaches which combine the possibility to evaluate the con-
tribution of allergens transport (MIE) to IEC activation and cytokine
production (KE1) are important tools for studying the immunogenic
properties of food proteins. The interaction of food allergens with the
intestinal epithelium not only leads to the secretion of innate cytokines,
but also the production of chemokines and other soluble factors such as
alarmins (e.g. uric acid, ATP, HMGB1, and S100 proteins) that drive
immune polarization by affecting DC function and the adaptive re-
sponse (Gavrovic-Jankulovic & Willemsen, 2015; van Bilsen et al.,
2017). Furthermore, there is evidence that mediators released by per-
ipheral blood mononuclear cells (PBMCs) and mast cells contribute to
increase intestinal permeability which means that immunologic status
can, by itself, affect IEC activation and the access of the allergen
through epithelium (Tordesillas et al., 2013).
In this sense, several strategies have already been attempted with
relative success. IEC lines grown in transwell systems (e.g. Caco-2, T84,
or HCT-8) have been used to assess allergen uptake and subsequent
epithelium activation by measuring cytokine production or changes in
gene expression induced by allergens (Starkl et al., 2011; Tordesillas
et al., 2013). In order to study the influence of intestinal soluble factors
from immune cells on IECs, some in vitro strategies have used separate
monocultures of IECs and immune cells and then supernatant from
immune cells has been applied to IECs (Martos, Lopez-Exposito,
Bencharitiwong, Berin, & Nowak-Wegrzyn, 2011; Tordesillas et al.,
2013; Yamashita, Yokoyama, Hashimoto, & Mizuno, 2016) or vice versa.
This strategy may contribute to a better comprehensive understanding
of the in vivo cross-talk affecting KE1.
In addition, co-culture systems allowing cross-talk between struc-
tural cells (IECs) and effector immune cells (such as basophils) are
being attempted to study whether a food allergen induces not only a
direct epithelial activation, but also its consequences on the underlying
immune cells, enabling to assess the immune cell responses through
epithelial activation. An in vitro model based on the co-culture of Caco-
2 cells and rat basophilic leukaemia cells (RBLs) has been used for the
study of immune activation upon Gal d 2 challenge at the apical side of
the IECs (Thierry, Bernasconi, Mercenier, & Corthesy, 2009). Although
not performed, epithelial activation markers may be evaluated using
this co-culture system.
More complex co-cultures combining mucoid IECs, non-mucoid IECs
and B cell lines (Caco-2/HT29/Raji-B) have been suggested in the
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literature as systems to integrate allergen uptake with epithelial acti-
vation markers as well as with modulation by the immune cell signals
(Araujo & Sarmento, 2013). However, such an integrative system has
not yet been used for the study of food allergens.
3. Dendritic cells
3.1. In vitro models to assess dendritic cell activation and migration (KE2
and KE3)
As major antigen presenting cells, gut-associated DCs play a key role
in immunological pathways associated to food protein sensitization
process. Food proteins or their digestion products may induce activa-
tion of DCs (KE2) by C-type lectin receptor (CLRs) or other PRRs
leading to a decrease in TLR-induced IL-12 production, as well as up-
regulation of OX40L, TIM-4, or both. In addition, DCs can be activated
by IEC-derived IL-33 which also upregulates OX40L expression on DCs.
After allergen uptake and activation, DCs migrate (KE3) to draining
lymph nodes mediated by the expression of CCR2, CCR5 and CCR7
molecules. Other interesting surface markers to assess as indicators of
antigen presentation are HLA-DR (MHC class II), CD86 (Katayama
et al., 2013) and DC-SIGN binding by fluorescent-labeled food proteins
(Kamalakannan, Chang, Grishina, Sampson, & Masilamani, 2016).
Besides DC assays analyzing the presence of (binding to) surface
molecules and cytokine expression, other methods have been described
evaluating the differences in DC endocytosis by incubating murine bone
marrow-derived DCs (BM-DCs) with FITC-labeled β-lactoglobulin and
by in vitro endolysosomal degradation of the native and cross-linked
forms of this allergen (Stojadinovic, Pieters, Smit, & Velickovic, 2014).
These data indicated differences that correlated with the sensitizing
potential in vivo, suggesting that these additional parameters may be
useful in vitro parameters to evaluate the sensitizing potential of food
proteins. On this regard, BM-DCs have been applied to estimate the
effect of thermal process on ovalbumin and showed that a glycation
product of this allergen, pyrraline, induced higher uptake by DCs as-
sociated with the scavenger receptor class A (Heilmann et al., 2014).
Transcriptomic profiling of allergen-activated DCs is another ap-
proach to compare the DCs activating potency of food proteins.
Comparison of various cell lines with human monocyte-derived DCs
(moDCs) by gene profiling suggested that the MUTZ-3 cell line re-
sembles moDCs (Larsson, Lindstedt, & Borrebaeck, 2006). A clone of
this cell line has been recently used to assess and predict the sensitizing
potential of proteins in respiratory allergy in the Genomic Allergen
Rapid Detection (GARD) assay. In this assay, cellular responses induced
by eight selected proteins were assessed using transcriptional profiling,
flow cytometry and multiplex cytokine analysis. A total of 391 potential
biomarkers were identified as a predictive signature and series of cross-
validations supported the effectiveness of this model. These results to-
gether with biological pathway analysis of the transcriptomic data in-
dicate that the investigated cell system is able to capture relevant
events linked to type I hypersensitization (Zeller et al., 2018). Although
promising, the relevance of this model for food sensitization induction
in general remains to be established.
Migration assays using BM-DCs (Rhee, Zhong, Reizis, Cheong, &
Veillette, 2014) or MUTZ-3 cells (Rees et al., 2011) have been described
in transwell systems in which activated DCs are applied in the upper
chamber, whereas an appropriate chemokine is added to the lower
chamber. After incubation, migrated cells are harvested from the lower
chamber and quantified (Rhee et al., 2014). However, these migration
assays have never been proven useful in a food allergen specific context.
3.2. In vitro models to assess interactions between epithelial and dendritic
cells (approaches integrating KE1, KE2 and KE3)
The IECs- and DCs-derived signals constitute an allergen-induced
inflammatory microenvironment that triggers DCs maturation and
migration. Test methods incorporating IECs and DCs have been devel-
oped in a variety of formats: co-cultures of DCs/IECs, three-dimensional
(3D) models reconciling the complex and dynamic interactions that
exist in vivo between the intestinal epithelium and the luminal side, and
between the epithelium and the underlying immune system on the
basolateral side (Bermudez-Brito, Plaza-Diaz, Fontana, Munoz-
Quezada, & Gil, 2013). These methods have been applied to investigate
cellular and molecular mechanisms triggered by prebiotics and bac-
teria. However, the impact of allergens on these mechanisms has not yet
been investigated extensively with these test models. Cultures of DCs
supplemented with IEC-conditioned medium may also be considered as
alternatives to co-cultures. This method has been applied in the case of
prebiotics using human moDCs cultured with HT-29 conditioned
medium (de Kivit et al., 2017).
Although several studies have used cultures of IECs or DCs to assess
the sensitizing potential of food allergens, only the previously men-
tioned study from Tordesillas et al. investigated the influence of a food
allergen on the function of co-cultured IECs/DCs. In that study, a
transwell system with Caco-2 cells was set up, including PBMCs from
healthy donors in the basolateral compartment. The addition of the Pru
p 3 onto the apical chamber induced increased expression of IL-1β, IL-6,
IL-10 and TNF-α genes in PBMCs which was related to the high trans-
port rate of intact Pru p 3 over the Caco-2 barrier (Tordesillas et al.,
2013). These types of methods allow a further characterization of the
sensitizing potential of allergens by including the role of cell-cell con-
tact as well as soluble molecules taking into account the cellular in-
teractions. However, several specific limitations may be encountered
during the development of these methods, such as compatibility of cell
types or cell media, complexity of the systems, donor variability when
using primary human cells.
4. T and B cell differentiation
4.1. In vitro models to assess murine Th2 cell priming (KE4)
Allergens are thought to invoke an allergic response due to their
ability to activate T cells through their specific cell receptors (TCRs).
Besides this primary pathway, the interaction of co-stimulatory and co-
inhibitory receptors of T cells (CD28, CTLA-4, OX40L) with ligands on
antigen presenting cells activates antigen unspecific signals that lead to
the differentiation of T cells into a Th2 phenotype (van Bilsen et al.,
2017).
Due to the low allergen-specific T cell in vivo frequency, re-stimu-
lation of pre-sensitized cells ex vivo is the most widely used method to
evaluate priming potential of common food allergens in mice. Most
studies use splenocytes, mesenteric lymph node cells, or a combination
of both, although lamina propria mononuclear cells (Sun et al., 2016)
and isolated CD4+ T cells (Kanjarawi et al., 2011; Pochard et al., 2010)
have also been evaluated. Cell suspensions are prepared from im-
munized mice and cultured with the antigen for 3–6 days, depending on
the subsequent analyses. T cell proliferation, expression of specific
cellular surface markers and/or cytokine secretion are mostly de-
termined in these studies. T cell proliferation is one of the most
common ways to assess T cell activation upon ex vivo re-stimulation
with the allergen. To this end, several methods such as labeling of cells
with a fluorescent dye (Pochard et al., 2010; Sun et al., 2016), in-
corporate a radioactive nucleoside into new strands of chromosomal
DNA during mitotic cell division (Freidl et al., 2017; Stojadinovic et al.,
2014) or colorimetric assays for assessing cell metabolic activity (Sun,
Liu, Wang, Liu, & Feng, 2013; Wai, Leung, Leung, & Chu, 2016) have
been used.
Proliferation assays have been performed for β-lactoglobulin
(Mizumachi, Tsuji, & Kurisaki, 2008; Stojadinovic et al., 2014), oval-
bumin (Castro et al., 2012; Sun et al., 2016), tropomyosin (Capobianco
et al., 2008; Wai et al., 2016), Cyp c 1 from carp (Freidl et al., 2017),
peanut (Pochard et al., 2010), cashew and walnut extract (Kulis, Pons,
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& Burks, 2009), and soybean proteins (Sun et al., 2013), showing in all
the cases a strong proliferative response of the cells. Expression of
specific surface markers have been measured in sensitized mice after
challenge with whey and ovalbumin, showing an increase in the per-
centage of both, activated Th1 and Th2 cells compare to control animals
(Lozano-Ojalvo, Perez-Rodriguez, Pablos-Tanarro, Molina, & Lopez-
Fandino, 2017; Vonk et al., 2017). However, when peanut extract was
used there was no difference in the percentage of activated Th2 cells,
and the percentage of activated Th1 cells was decreased (Vonk et al.,
2017).
Levels of secreted cytokines are often evaluated by ELISA or flow
cytometry in cell culture supernatants. This method has been used to
evaluate several food allergens from cow's milk (Kanjarawi et al., 2011;
Stojadinovic et al., 2014), peanut (Smit et al., 2015; Zhu et al., 2016),
hen's egg (Pablos-Tanarro, Lopez-Exposito, Lozano-Ojalvo, Lopez-
Fandino, & Molina, 2016; Sun et al., 2016), soybeans (Sun et al., 2013)
and shrimp (Wai et al., 2016). Moreover, extracts from whey, hen's egg
white, peanut, cashew, walnut and sesame seeds have also been eval-
uated using this method (Lozano-Ojalvo et al., 2017; Smit et al., 2015;
Vonk et al., 2017). A high increased secretion of Th2 cytokines (IL-4, IL-
5, IL-13) has been observed in all the studies, whereas some dis-
crepancies were observed between allergenic proteins in their potency
to induce IFN-γ (Stojadinovic et al., 2014; Vonk et al., 2017) and IL-10
(Vonk et al., 2017). A few studies have measured increased levels of IL-
17 (Lozano-Ojalvo et al., 2017; Rupa, Nakamura, Katayama, & Mine,
2014), while in other limited number of studies IL-22 and TNF-α levels
showed no differences compared to non-sensitized control cells (Pablos-
Tanarro et al., 2016; Zhu et al., 2016).
The assays described above, have provided efficacy to identify
known allergens that drive allergic reactions in individuals and allergen
modifications that ameliorate their allergenic potential, as well as to
identify T cell epitopes of cross-reactivity with other allergens.
However, they are not effective to identify the allergenic potential of
new proteins that are responsible for stimulating the underlying Th2
responses, mainly due to the need to use cells from previously sensitized
mice against the same allergen to perform the assay. Moreover, al-
though evaluation of T cell activation through T cell proliferation as-
says is widely describe in the literature using different strategies, the
use of indirect methods such as those that measure mitochondrial ac-
tivity (e.g. MTT or WST assays) should be avoided because they reflect
viable cell metabolism and not specifically cell proliferation, requiring
additional confirmations.
4.2. In vitro models to assess human Th2 cell priming (KE4)
The activation and priming of naive T cells (KE4) for allergic food
proteins in the draining lymph nodes results from the recognition of an
epitope presented by Th2 driving DCs in the context of HLA (MHC-II).
Most of the approaches for investigating KE4 using human samples are
based on the ex vivo re-stimulation of PBMCs from allergic patients and
the study of the allergen-specific induced proliferation and cytokine
production (Flinterman et al., 2010; Tao et al., 2016; Tiemessen et al.,
2004; Vocca et al., 2011). Indeed, stimulation of PBMCs from cow's
milk allergic children with β-lactoglobulin was found to induce cell
proliferation and increased IL-13 over IFN-γ release compared to
healthy or tolerant controls (Vocca et al., 2011). Also in PBMCs from
peanut allergic patients, allergen-specific proliferation could be as-
sessed by determining proliferation within the CD25 + CD134 + CD4+
T cell population after stimulation with raw peanut (Tao et al., 2016).
However, in peanut allergic patients, ex vivo stimulation of PBMCs with
peanut extract increased both IL-13 and IFN-γ as well as TNF-α levels
compared to PBMCs from healthy controls (Flinterman et al., 2010).
However, as pointed out in the previous section for KE4, the pre-
cursor frequency of allergen-specific T cells is very low in the peripheral
blood of allergic patients. In this regard, the generation of T cell lines
and T cell clones is an interesting alternative that lead to analyze Th2
cell activation (Flinterman et al., 2010; Tiemessen et al., 2004). Assays
to study the functionality of these allergen-specific T cells make the use
of allergen induced selection and cloning to improve the sensitivity of
the assay. A mixture of β-lactoglobulin derived synthetic peptides were
used to generate antigen-specific T cell lines and clones from PBMCs of
cow's milk allergic patients (Sakaguchi et al., 2002). Limiting dilution
clones were isolated and then used for epitope mapping. Results
showed a sequence of 12 amino acids recognized by three out of six T
cell clones from 5 different patients, which was associated with pre-
sentation via HLADRB1*0405 (Sakaguchi et al., 2002). Kondo et al.
further studied intracellular cytokine expression in two of those clones,
showing an increased production of IL-4 and IFN-γ both in combination
with IL-10 (Kondo et al., 2005). In this sense, cytokine release mea-
surement may provide additional information concerning the type of
immune response that is raised against these epitopes. Tiemessen et al.
generated T cell clones using whole cow's milk proteins and compared
the cytokine response in a group of cow's milk allergic infants with non-
symptomatic allergic patients and healthy donors (Tiemessen et al.,
2004). Results showed that all different groups strikingly reacted to
milk proteins, although cytokine production by allergic individuals was
the highest for IL-4, IL-13, IFN-γ, and IL-10 (Tiemessen et al., 2004).
However, only the symptomatic group revealed a negative or no cor-
relation between IL-4/IFN-γ and IL-10, while in the other two groups
there was a positive correlation, showing the importance of IL-10 as a
regulatory cytokine involved in tolerance induction. In addition, T cells
from the symptomatic group had a high expression of the activation
marker CD69 (Tiemessen et al., 2004). Beyond studying differences in T
cell phenotype between patients and controls, T cell epitope disruption
can also be studied using T cell lines as showed by the fact that β-
lactoglobulin was able to induce a higher proliferation and cytokine
secretion than its products of hydrolysis (Knipping et al., 2012). In
short-term peanut-specific T cell lines generated from PBMCs of peanut
allergic patients, Ara h 1, Ara h 3, and Ara h 6 were identified to induce
the highest proliferation and secretion of IL-13, showing that these cell
lines created using crude peanut extract can be useful for allergen
identification (Flinterman et al., 2010). Furthermore, allergen-specific
T cell clones from HLA diverse donors can be generated in order to
evaluate the epitopes involved in T cell activating capacity in a certain
HLA context (Prickett et al., 2011, 2013). This method has been used to
identify 10 core epitopes of Ara h 1 and 5 core epitopes of Ara h 2 that
could effectively induce T cell proliferation in a HLA-DQ and/or HLA-
DR and/or HLA-DP restricted manner (Prickett et al., 2011, 2013). In
the latter study, it was also showed that Ara h 2 peptides were able to
enhance IL-4 and IL-5 secretion (ELISPOT) in PBMCs from peanut al-
lergic donors (Prickett et al., 2011).
Based on an in silico predictions, Ramesh et al. evaluated the im-
munogenic potential of 36 Ara h 1 derived peptides studying pro-
liferation and cytokine production after ex vivo re-stimulation of PBMCs
from peanut allergic patients with those peptides (Ramesh et al., 2016).
Almost all the in silico selected peptides induced proliferation and
predominantly a high IL-13 release when compared to IFN-γ (Ramesh
et al., 2016). This study indicates that PBMCs from allergic donors,
combined with an appropriate in silico prediction, may yet be sufficient
to identify allergenic epitopes of certain food proteins. In addition,
MHC-peptide tetramers assays have been previously used to identify
allergen-specific T cells in PBMCs. DeLong et al. cultured PBMCs from
peanut allergic patients with Ara h 1 peptides loaded on biotinylated
HLA-DR proteins and intracellular cytokine expression was identified in
tetramer labeled cells (Delong et al., 2011). Results showed that CCR4
expressing Ara h 1 reactive T cells responded to different epitopes and
produced mostly IL-4 beyond other cytokines (Delong et al., 2011).
In these types of assays, allergen-specific T cells can be identified by
a highly upregulated Th2-prone culturing environment. They may not
provide much information regarding the sensitizing potential of a given
food protein, but merely indicate whether specific (or novel) food-de-
rived proteins or peptides can be recognized by T cells and pose a
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potential risk. Moreover, these approaches are useful to identity novel
food epitopes that are recognized by T cells.
4.3. In vitro models to assess DC activation/migration and T cell priming
(approaches integrating KE2, KE3 and KE4)
After DC activation (KE2 and KE3), DCs migrate to the draining
lymph nodes and drive T cell activation and differentiation (KE4). In
vitro models to study antigen presentation and polarization of Th0 to-
ward Th2 cells are usually based on co-culture approaches using DCs
and primed T cells.
In methods based on murine cells, BM-DCs have been co-cultured
with CD4+ T cells from mice sensitized to peanut (Pochard et al.,
2010), whey (Stojadinovic et al., 2014) and a panel of purified food
proteins (Smit, de Zeeuw-Brouwer, van Roest, de Jong, & van Bilsen,
2016). In addition, CD4+ T cells have also been obtained from TCR
transgenic strains such as DO11.10 (Ilchmann et al., 2010) or OT-II
mice (Rhee et al., 2014). These studies have showed that DCs increased
the expression of activation/migration markers (MHC-II, CD80, and
CD86) and the release of stimulatory cytokines such as IL-6 and IL-12
after re-stimulation with the allergen. Furthermore, activated DCs in-
duce a high proliferation and a marked Th2 profile (enhanced pro-
duction of IFN-γ, IL-4, IL-13, and IL-5 determined by ELISA) in primed
CD4+ T cells. Similar results were obtained when DCs were directly
isolated from mesenteric lymph nodes and co-cultured with CD4+ T
cells from DO11.10 mice (Blazquez & Berin, 2008).
Among human in vitro models, DCs used for co-culture with T cells
have been obtained from differentiated THP-1 cell line (Katayama et al.,
2013) and allergen-pulsed monocyte-derived DCs (Gomez et al., 2012;
Scott-Taylor, Axinia, & Strobel, 2017). Allergens have been shown to
activate DCs revealed by an enhanced expression of CD80, CD83, and
CD86 (Gomez et al., 2012), production of inflammatory cytokines (IL-
12p70, IL-1β, TNF-α, and IL-10) and up-regulated expression of
MARCH genes. For the study of the cross-talk with T cells, PBMCs from
healthy donors (Tordesillas et al., 2013) or cashew allergic patients
(Archila et al., 2016) have been previously used. In addition, T cell lines
generated from cow's milk allergic children (Meulenbroek et al., 2014)
and CD4+ T cells directly isolated from patient allergic to peach
(Gomez et al., 2012) and other food allergens (Scott-Taylor et al., 2017)
have been previously used for co-cultures. Results have shown that, in
presence of the food allergen, DCs induce T cell proliferation (observed
by flow cytometry using carboxyfluorescein succinimidyl ester mole-
cule -CFSE- or CD154 staining) in sensitized individuals compared to
healthy donors. In addition, allergen-pulsed DCs trigger activation of T
cells and increase the production of T cell-like cytokines such as IL-4,
IL-13, and IFN-γ.
One of the strengths of human in vitro models is the use of T cells
from allergic patients in an autologous setting, although it coincides
with a downside, the limited number of cells that can be used
(Lundberg et al., 2008). In addition, there are variations in the ex-
perimental protocols used for pulsed-DCs alone with the allergen of
interest (Gomez et al., 2012; Scott-Taylor et al., 2017) or combined
with maturation factors, such as TNF-α, IL-1β, or LPS (Ashjaei et al.,
2015). These differences during maturation can affect expression of DC
co-stimulatory and maturation markers and thus the subsequent pro-
liferation of T cells and cytokine production, although most of the
studies were able to induce an allergen-specific response. Despite dif-
ferences between the in vitro models, co-cultures of DCs/T cells provide
useful information about antigen presentation and polarization ability
of DCs in presence of primed CD4+ T cells.
4.4. In vitro models to assess B cell isotype switching (KE5)
The mechanisms controlling the induction of class switch re-
combination and production of IgE by switched B cells have been stu-
died extensively. In vitro, the production of IgE by human B cells,
specifically induced by IL-4 or IL-13 and signalling via CD40 cell surface
molecule, can be monitored at various levels of the ε class switching
process, including during the induction of the sterile ε transcript, which
precedes Ig heavy chain locus rearrangement by quantitative reverse
transcription PCR (RT-qPCR) or Northern blot assay, the detection of
production of ε excision circles during the Ig heavy chain locus re-
arrangement by PCR and the detection of production of IgE by ELISA as
nicely reviewed by Pène et al., 2005.
Even though several in vitro B cell activation protocols are available
(Lin & Calame, 2004; Pène et al., 2005), to the best of our knowledge no
protocols have been established so far that investigate the (various le-
vels of) class switching in a food allergen-specific context.
5. Future perspective
5.1. In vitro micro-fluidics systems
Advances in micro-physiological systems are providing researchers
alternative means to gain insights into the molecular interactions of the
gastrointestinal tract. These systems combine the benefits of micro-
engineering, micro-fluidics, and cell culture in a bid to recreate the
environmental conditions prevalent in the human gut. It becomes now
possible to construct in vitro systems that more closely approximate
those conditions present within the gut on scales identical to those
encountered in vivo (Kim, Huh, Hamilton, & Ingber, 2012). These sys-
tems based on micro-fluidics offer numerous advantages over tradi-
tional cell-culturing techniques, including a 3D culture environment,
greater experimental flexibility, the ability to precisely tune spatio-
temporal oxygen and pH gradients, low shear environments, and the
ability for high throughput experimentation. Although currently
available micro-fluidics systems provide promising approaches to study
local mechanisms that drive allergic responses, they have not yet been
used to study any of the MIE or KE including in the AOP for food
sensitization. Some examples of available micro-fluid devices are de-
scribed below.
5.1.1. Human gut-on-a-chip device
A micro device “human gut-on-a-chip” has been developed by the
Ingber group at Harvard University, which is composed of two micro-
fluidic channels, separated by a porous flexible membrane coated with
extracellular matrix and lined by Caco-2 cells to mimics the complex
structure and physiology of living intestine. The gut micro-environment
is established by flowing fluid, which produces low shear stress over the
micro-channels and exerts cyclic strain that mimics physiological
peristaltic motions (Kim et al., 2012).
5.1.2. NutriChip
NutriChip is another integrated micro-fluidic platform developed by
Swiss scientists for investigating potential immunomodulatory function
of dairy food and represents a miniaturized artificial human gastro-
intestinal tract (Ramadan et al., 2013). NutriChip is a culture of a
confluent layer of Caco-2 cells separated from co-cultured immune cells
by a permeable membrane, which allows studying processes that
characterize the passage of nutrients though the intestinal epithelium,
including the activation of immune cells. NutriChip allows application
of in vitro digested food on its apical side and a basolateral culture of a
monocyte line (U937 cells) differentiated into macrophages (Ramadan
et al., 2013).
5.1.3. Immuno-HuMiX
Human-microbial cross-talk platform (HuMiX) is also a micro-fluid
device that enables the study of molecular interactions at the host-mi-
crobe interface (Eain et al., 2017). The features of HuMiX are similar to
those of the other fluidics systems in which also the microbiome com-
ponent may be introduced. Moreover, the system can be expanded to
analyze the interactions between the immune system and the intestinal
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microbiota in the human gut, the so called Immuno-HuMix model. First
steps have been undertaken to integrate human PBMCs in this system
(Eain et al., 2017).
5.2. Organotypic ex vivo cultures
One of the major weaknesses of IEC lines is that they are different
from the primary cells of the intestinal epithelium, from which they had
originally been isolated. The selection of cells that survive and expand
in vitro often leads to changes in gene expression profile and altered
responses. In this respect, primary isolated cells may therefore be a
better model system to represent processes in the intestinal mucosa.
Promising ex vivo approaches are the generation of intestinal organoids
and the culturing of ex vivo intestine samples.
5.2.1. Intestinal organoids
Major advances have been made in establishing culture conditions
that support the long-term propagation and self-organisation of near-
physiological tissue. In general, isolated somatic stem cells from various
organs are cultured in the presence of specific small molecules and
growth factors, reflecting essential niche components of the respective
tissue of origin. A 3D scaffold mimicking the basal lamina has further
been shown to support ex vivo expansion of intestinal stem cells ex vivo
and tissue formation that resembles part of the cellular architecture,
hierarchy and physiology of the in vivo counterpart (Sato & Clevers,
2013). The culture of intestinal crypts and their growth and differ-
entiation to organoids may be an interesting and easy to handle tool to
study allergen interaction and associated signal transduction pathways
in a complex intestinal system.
Despite the requirement for more expensive technology than IEC
lines, intestinal organoids have been shown to have multiple applica-
tions and with the recent development of efficient gene-editing tools, it
is now possible to generate highly physiological models of human
gastrointestinal diseases (Leushacke & Barker, 2014). However, the
study of allergen transport across the epithelial barrier is limited by the
inaccessibility of food proteins to the apical side of IECs (directed to the
lumen of the organoids).
5.2.2. Ex vivo models
Another approach to overcome the major drawbacks of the in vitro
cell line-based models may be the use of complete intestinal tissues. In
these models, the asymmetrical distribution of proteins and lipids in the
two plasma membrane domains is facing the intestinal lumen. The in-
ternal milieu and the presence of highly organized structures joining
adjacent IECs, enable selective processes of absorption, transport, and
secretion to take place across the intestinal mucosa. The main ex vivo
intestinal models for intestinal protein transport studies include the
everted sac technique and the Using chamber. These approaches have
been largely used to assess protein transport and, using intestinal tissue
from sensitized animals, they may lead to study the effect of sensiti-
zation on allergen uptake. However, both techniques have several
limitations including the rapid loss of the tissue viability and tissue
damages during isolation, which may lead to overestimation of protein
transport. Furthermore, the presence of the muscle layer in the everted
sac method may lead to underestimation of protein transport. On the
other hand, interspecies differences complicate extrapolation of data to
humans. In this respect, pigs share more physiological and im-
munological similarities with humans than rodents and the recently
developed InTESTine™ method may be a medium-throughput alter-
native. InTESTine™ is based on intestinal tissues from pigs that are in-
cubated on a rocker platform in a high oxygen incubator (Westerhout
et al., 2014).
5.3. In silico approaches
In silico methodologies and tools like databases and comparison
software have been shown useful for the assessment of potential aller-
genicity of food proteins based on their properties. These in silico
methods use a number of physico-chemical features (mainly amino acid
searches) of proteins that can be predicted, such as B cell epitopes, T
cell epitopes and sequence homologies (as reviewed by Hayes, Rougé,
Barre, Herouet-Guicheney, & Roggen, 2015). They can identify whether
a novel protein is an existing allergen and/or has the potential to cross-
react with an existing allergen. However, they cannot identify whether
a novel protein will ‘become’ an allergen, so therefore these approaches
have limited value to identify truly novel allergenic proteins (Hayes
et al., 2015). The use of future innovative in silico approaches will be
largely influenced by the choice of databases and algorithms that will
be developed, standardized, and most importantly, empirically vali-
dated.
6. Conclusion
Although basic science studies have identified a lot of immune
pathways behind the allergic response, sensitization to food proteins is
a complex process involving several molecular and cellular events
(Sicherer & Sampson, 2018; Tordesillas, Berin, & Sampson, 2017). The
simplification of the biological process of food allergy sensitization by
applying the AOP concept is an effective strategy to identify in vitro
methods that lead to investigate the sensitizing potential of food pro-
teins. Previously, such an approach focusing on MIE and KE described
in reported AOPs for skin and respiratory sensitization have been used
successfully to study the sensitizing potential chemicals in skin and
respiratory allergy (Ezendam, Braakhuis, & Vandebriel, 2016; Sullivan
et al., 2017).
In this review, we have clustered, structured, and discussed the
existing in vitro models that are suitable to study the MIE and KE in-
volved in the AOP for food allergy sensitization (van Bilsen et al.,
2017). To the best of our knowledge, this is the first time that the AOP
concept is applied to structure all available in vitro methods to identify
the potential sensitizing capacity of food proteins. In order to re-
capitulate all the reviewed assays, focusing on different (combinations
of) MIE and KE reflecting the different building blocks of the AOP,
Table 1 summarized in vitro methods used to evaluate the three major
food allergens: chicken ovalbumin (Gal d 2), bovine β-lactoglobulin
(Bos d 5) and peanut 2S albumin (Ara h 2).
In general, in vitro methods assessing mechanisms involved in the
innate immune response are easier to address than assays assessing the
adaptive immune response of food sensitization: the recognition mo-
lecules used by the innate system (here reflected in MIE, KE1, KE2, and
KE3), are expressed broadly on a large number of cells, which makes it
easier to develop in vitro methodologies to study specific building
blocks of the AOP, as seen by the rich set of available tools. However,
more in vitro studies of the transcellular transport based on epithelial
receptors (MIE2) or unspecific endocytosis (MIE3) should be carried out
to better understand the effect of this type of intestinal acquisition in
the sensitizing potential of food proteins.
On the other hand, the adaptive immune system (here reflected in
KE4 and KE5) is composed of small numbers of T and B cells with
specificity of any individual allergen. Therefore the responding cells
must proliferate after encountering the allergen in order to attain suf-
ficient numbers to mount an effective response that can be detected.
This feature of the adaptive system complicates the development of in
vitro approaches to assess KE4 and KE5. This is also reflected in Table 1
which depicts a limited number of in vitro approaches to address KE4
and the absence of an available in vitro assay to assess B cell isotype
switching (KE5) in a food-allergen specific context.
It must be noted that the in vitromodels discussed in this manuscript
have been developed to obtain a better understanding of the processes
involved in food sensitization. Several of the described in vitro models
(summarized in Table 1) seem to be correlated with the sensitizing
potential in vivo and some show great promise to closely approximate in
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vivo conditions (e.g. in vitro micro-fluidics systems and organotypic
cultures), however as far as we know, none of the described models
have been successfully used to assess the sensitizing potential of a given
food protein by comparing high and low/none sensitizing food proteins
in the assay. To this end, it would be an essential step forward to ex-
pand the panel of tested food proteins by including also low/non-al-
lergenic proteins. Most likely, none of the assays will be able to dis-
tinguish high from low/non allergenic potency by itself; however the
assays combined can provide an important set of data which may be
helpful to decide which of the assays are essential to be part of the
weight-of-evidence approach to determine the sensitizing potential of
food proteins. Unfortunately, to date it is not known whether the lack of
a suitable in vitro model to assess KE5 (B cell isotype switching) will
result in a crucial data gap to determine the sensitizing potential or
whether the KE5-model is redundant in the overall assessment.
In vitromodels based on cell lines are very useful as research tools to
investigate MIE and KE involved in food allergy sensitization. However,
the closer these cell-based systems are to the actual target tissue, the
better conclusions can be drawn. The main problem was that long-term
propagation of native, non-transformed single cells or cell clusters from
the intestine was not feasible and it was generally assumed that it
would not be possible to establish long-term cultures of primary adult
tissues without the introduction of genetic transformations promoting
cell proliferation and survival. In recent years, significant progress has
been made in this field and robust systems have been identified. A
variety of in vitro micro-fluidics systems and ex vivo culture strategies
has been developed to investigate the function of the intestinal mucosa,
which will help to increase the knowledge of food sensitization process.
Concluding, the application of the AOP framework offers the op-
portunity to anchor existing testing methods to specific building blocks
of the AOP for food sensitization which provides insight which specific
methods are available and which still need to be developed. When
applied in the context of an integrated testing strategy, such an ap-
proach may reduce, if not replace, current animal testing approaches.
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